Search clinical trials for: Caprelsa (vandetanib)
Total 104 results
-
National Cancer Institute (NCI)CompletedMultiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Medullary Thyroid CarcinomaUnited States
-
Samsung Medical CenterAstraZenecaCompleted
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerUnited States, France
-
Genzyme, a Sanofi CompanyCompletedEvaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer (VERIFY)Differentiated Thyroid CancerUnited States, Sweden, Brazil, Italy, Poland, Spain, China, Russian Federation, France, Japan, Denmark, Czechia
-
Genzyme, a Sanofi CompanyCompletedThyroid CancerItaly, Spain, Romania, Netherlands, Canada, United States, Switzerland, Australia
-
Genzyme, a Sanofi CompanyWorldwide Clinical TrialsCompletedSymptomatic, Aggressive, Sporadic, Unresectable, Locally | Advanced/Metastatic Medullary Thyroid Cancer (MTC)Belgium, Italy, Netherlands, Spain, France, Germany, United Kingdom, Luxembourg
-
National Cancer Institute (NCI)TerminatedRenal Cell Carcinoma | Renal Cell Cancer | Hereditary LeiomyomatosisUnited States
-
University of LiverpoolAstraZenecaUnknownPancreatic CancerUnited Kingdom
-
National Cancer Institute (NCI)Terminated
-
University College, LondonAstraZeneca; Cancer Research UKWithdrawnParaganglioma | PhaeochromocytomaUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedMetastatic Medullary Thyroid CancerBelgium
-
National Cancer Institute (NCI)CompletedRenal Cancer | Von Hippel LindauUnited States
-
Genzyme, a Sanofi CompanyCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedThyroid Cancer, Medullary | Thyroid Cancer | Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Poorly Differentiated Thyroid Gland Carcinoma | Follicular Thyroid CancerUnited States
-
Genzyme, a Sanofi CompanyActive, not recruitingTo Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerThyroid CancerUnited States, Italy, Poland, Russian Federation, United Kingdom, Netherlands, Israel, Czechia, India
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyCompleted
-
M.D. Anderson Cancer CenterUnited States Department of Defense; AstraZenecaCompleted
-
St. Jude Children's Research HospitalCompletedBrain and Central Nervous System TumorsUnited States
-
Genzyme, a Sanofi CompanyCompletedThyroid NeoplasmsSweden, France, Spain, Norway, Belgium, Denmark, Switzerland
-
Genzyme, a Sanofi CompanyCompletedUnresectable Locally Advanced or Metastatic, Medullary Thyroid CarcinomaJapan
-
Genzyme, a Sanofi CompanyActive, not recruitingMedullary Thyroid Cancer | Locally Advanced or Metastatic Medullary Thyroid CancerAustralia, Austria, Belgium, Brazil, Bulgaria, Canada, China, Czechia, Denmark, Finland, Germany, Greece, India, Israel, Italy, Korea, Republic of, Poland, Russian Federation, Sweden, United Kingdom
-
Genzyme, a Sanofi CompanyCompleted
-
Genzyme, a Sanofi CompanyActive, not recruitingThyroid CancerUnited States, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark, France, Germany, Hungary, India, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Spain, Sweden, Switz...
-
Velindre NHS TrustAstraZeneca; Cancer Research UKUnknownNeoplasmsUnited Kingdom
-
Genzyme, a Sanofi CompanyCompletedCarcinoma, HepatocellularTaiwan
-
National Cancer Institute (NCI)Terminated
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingMedullary Thyroid CancerUnited States, Canada, Spain, China, Taiwan, Australia, Japan, India, Belgium, Germany, France, Netherlands, Czechia, Brazil, Korea, Republic of, United Kingdom, Italy, Israel, Greece, Poland, Russian Federation
-
Cancer Research UKAstraZenecaCompletedCancer | Non Small Cell Lung CancerUnited Kingdom
-
University of Colorado, DenverAstraZenecaCompleted
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedNon-Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)Completed
-
Genzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)TerminatedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States
-
UNICANCERAstraZeneca; Intergroupe Francophone de Cancerologie Thoracique; Fondation ARCCompletedNon-small Cell Lung Cancer MetastaticFrance
-
Genzyme, a Sanofi CompanyTerminatedOvarian CancerGermany
-
Ronald WeigelAstraZenecaTerminatedInvasive Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedGlioblastoma Multiforme | Gliosarcoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Anaplastic Mixed OligoastrocytomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant NeoplasmUnited States
-
SanofiTerminatedNon-small Cell Lung Cancer (NSCLC)Netherlands
-
PrECOG, LLC.AstraZenecaCompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedCarcinoma, Hepatocellular | Metastatic Colorectal CancerUnited Kingdom
-
SanofiCompletedPancreatic CancerSwitzerland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Terminated
-
Genzyme, a Sanofi CompanyTerminated
-
Genzyme, a Sanofi CompanyCompletedCarcinoma | Lung Cancer | Non-Small Cell Lung
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
SanofiCompleted
-
Hoffmann-La RocheWithdrawn